Skip to main content
. Author manuscript; available in PMC: 2018 Feb 13.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2015 Jun 25;93(3):631–638. doi: 10.1016/j.ijrobp.2015.06.021

Table 3.

Multivariate Analysis combining RSI and Molecular Subtype in Breast Cancer

Variable Level Compared to Ref Hazard Ratio P Value
subtypebyge_RSI HER2, Resistant 3.048 (0.776, 11.971) 0.1103
Ref: TN, Resistant HER2, Sensitive/Int 0.608 (0.169, 2.179) 0.4447
LUMA, Resistant 0.232 (0.079, 0.683) 0.008
LUMA, Sensitive/Int 0.308 (0.132, 0.717) 0.0063
LUMB, Resistant 0.334 (0.119, 0.936) 0.0369
LUMB, Sensitive/Int 0.494 (0.214, 1.139) 0.0979
TN, Sensitive/Int 0.239 (0.088, 0.648) 0.0049
age 0.941 (0.907, 0.977) 0.0014
rttotaldose >66Gy 0.686 (0.409, 1.15) 0.1531
pT pT2-3 1.083 (0.711, 1.651) 0.7094
surgicalmargin marg+ 1.517 (0.771, 2.988) 0.2277
pN pN+ 1.048 (0.522, 2.103) 0.8956
ct ChT 0.738 (0.376, 1.449) 0.3773
ht HT 2.064 (1.099, 3.878) 0.0243

• Only 9% of all patients received HT